Intended for healthcare professionals


Malaria vaccine difficult to roll out because four doses are needed, WHO says

BMJ 2015; 351 doi: (Published 26 October 2015) Cite this as: BMJ 2015;351:h5706
  1. Anne Gulland
  1. 1London

An antimalaria vaccine for children will be piloted in up to five demonstration sites before being recommended for widespread use, a World Health Organization expert committee has announced.

A phase III trial showed that the RTS,S vaccine, which acts against Plasmodium falciparum, had an efficacy of around 30%.1 The vaccine, which is most effective in children aged between 5 months and 17 months, is given in three …

View Full Text

Log in

Log in through your institution


* For online subscription